A Study of Pharmacokinetics of Atorvastatin on Type 2 Diabetic & Dyslipidemic Bengali Population of India and Bangladesh (original) (raw)
Atorvastatin in the Treatment of Hypercholesterolemia in High Risk Cardiovascular Patients in Bangladesh
Hajera Mahtab
BIRDEM Medical Journal, 2012
View PDFchevron_right
Lipid modifying action of atorvastatin in escalating doses in patients of coronary artery disease
Sajjad Hossain
International Journal of Basic & Clinical Pharmacology, 2014
View PDFchevron_right
Effect of atorvastatin on non-cholesterol sterols in patients with type 2 diabetes mellitus and cardiovascular disease
Tomas Haas
Pharmacological Research, 2005
View PDFchevron_right
Prolonged inhibition of cholesterol synthesis explains the efficacy of atorvastatin
Loukianos Rallidis
View PDFchevron_right
Comparative efficacy study of atorvastatin vs. simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia
Salvatore Turco
Diabetes, Obesity and Metabolism, 2000
View PDFchevron_right
Effective Analysis of Atorvastatin Versus in Simvastatin Patients with Hyperlipidemia
JAWAHAR FAROOK
2009
View PDFchevron_right
STUDY OF PLASMA LEVEL OF ATORVASTATIN AND ITS EFFECT ON LIPID PROFILE
heema valera
View PDFchevron_right
The Comparison of Simvastatin and Atorvastatin Efficacy in Lowering Lipid Profile and Apolipoprotein-B of Diabetic Dyslipidemia Patient
Sony Wibisono
2013
View PDFchevron_right
Effects of atorvastatin treatment on the oxidatively modified low density lipoprotein in hyperlipidemic patients
Quansheng Zhu
Molecular and cellular biochemistry, 2000
View PDFchevron_right
Comparative Study of Efficacy of Atorvastatin 40 Mg Daily Rosuvastatin 20 Mg Daily And Rosuvastatin 20 Mg Alternate Day Day ,Among Diabetic Patients.A Study Of 300 Patients
Mukul Misra
IOSR Journal of Dental and Medical Sciences, 2017
View PDFchevron_right
Efficacy and safety of atorvastatin in hyperlipidemic, type 2 diabetic patients. A 34-week, multicenter, open-label study
Germán Orozco
Atherosclerosis, 2000
View PDFchevron_right
Atorvastatin action involves diminished recovery of hepatic HMG-CoA reductase activity
Gene Ness
Journal of lipid research, 1998
View PDFchevron_right
A Comparative Study to Evaluate Efficacy and Safety of Daily Dosing versus Alternate-Day Atorvastatin Therapy in Patients with Dyslipidemia
Dr. Syed Salman Farookh, MD
Pharmacology and Clinical Pharmacy Research
View PDFchevron_right
Comparative study of low doses of rosuvastatin and atorvastatin on lipid and glycemic control in patients with metabolic syndrome and hypercholesterolemia
Ji-yong Choi
The Korean journal of internal medicine, 2010
View PDFchevron_right
Comparison of the efficacy and safety of atorvastatin initiated at different starting doses in patients with dyslipidemia
Ole Faergeman
American Heart Journal, 2005
View PDFchevron_right
Effects of atorvastatin 10 mg/d on insulin resistance: A 12-week, open-label study in hyperlipidemic patients
Oguz Yavuzgil
Current Therapeutic Research, 2006
View PDFchevron_right
The lipid-lowering effect of atorvastatin in Taiwanese diabetic patients with hyperlipidemia
Wayne H.-h. Sheu
Tzu Chi Medical Journal, 2013
View PDFchevron_right
To compare rosuvastatin with atorvastatin in terms of mean change in LDL-C in patient of diabetes mellitus
Zain Masood
The Professional Medical Journal, 2020
View PDFchevron_right
Atorvastatin reduces blood serum cholesterol in Wistar rats fed a high cholesterol diet (undergraduate thesis paper)
Alfred Wong
View PDFchevron_right
Comparison of Lipid Lowering Effects of Rosuvastatin and Atorvastatin in Type 2 Diabetic Patients with Primary Hyperlipidemia
Maria Yousaf
Pakistan Armed Forces Medical Journal, 2020
View PDFchevron_right
Comparative Study on Effectiveness and Safety of Atorvastatin with Rosuvastatin in Hyperlipidemic Patients at a Tertiary Care Hospital in Nepal
Anjan Khadka
Journal of Institute of Medicine Nepal
View PDFchevron_right
The Effects of Atorvastatin Consumption on Biochemical Variables in Patients with Type 2 Diabetes Mellitus and Pre-diabetes
Karimollah Hajian-Tilaki
International Journal of Medical Laboratory
View PDFchevron_right
Effects of atorvastatin on the HDL subpopulation profile of coronary heart disease patients
Bradley Asztalos
The Journal of Lipid Research, 2002
View PDFchevron_right
Atorvastatin Causes Insulin Resistance and Increases Ambient Glycemia in Hypercholesterolemic Patients
Michael J Quon
Journal of the American College of Cardiology, 2010
View PDFchevron_right
Effect of atorvastatin on highdensity lipoprotein cholesteroland its relationship withcoronary events: a subgroupanalysis of the GREekAtorvastatin and Coronary-heart-disease Evaluation (GREACE) Study
Vasilios Athyros
Current Medical Research and Opinion, 2004
View PDFchevron_right
Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin
J. Ducobu, Yvon Carpentier
International Journal of Cardiology, 2005
View PDFchevron_right
Effect of Atorvastatin on Glycaemic Parameters in Normoglycaemic and Prediabetic Subjects: A Prospective, Panel Study
Dr. Sansita Parida
Journal of clinical and diagnostic research : JCDR, 2017
View PDFchevron_right
Plasma pre β-HDL formation is decreased by atorvastatin treatment in type 2 diabetes mellitus: Role of phospholipid transfer protein
Arie Van Tol
Biochimica and Biophysica Acta Molecular and Cell Biology of Lipids, 2009
View PDFchevron_right
Inhibition of cholesterol synthesis by atorvastatin in homozygous familial hypercholesterolaemia
Maritha Kotze
Atherosclerosis, 2000
View PDFchevron_right